ACADIA PHARMACEUTICALS INC. Liabilities, Noncurrent
ACADIA PHARMACEUTICALS INC. (ACAD) had Liabilities, Noncurrent of $1.56 million as of 2018-12-31, per its 10-K filed 2019-02-27.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LiabilitiesNoncurrent · last filed 2019-02-27
- 2018-12-31: Liabilities, Noncurrent $1.56M.
- 2018-09-30: Liabilities, Noncurrent $1.21M.
- 2018-06-30: Liabilities, Noncurrent $1.03M.
- 2018-03-31: Liabilities, Noncurrent $782.00K.
| Period end | Liabilities, Noncurrent |
|---|---|
| 2018-12-31 | $1.56M 10-K · filed 2019-02-27 |
| 2018-09-30 | $1.21M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $1.03M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $782.00K 10-Q · filed 2018-05-04 |
| 2017-12-31 | $191.00K 10-K · filed 2019-02-27 |
| 2017-09-30 | $245.00K 10-Q · filed 2017-11-07 |
| 2017-06-30 | $262.00K 10-Q · filed 2017-08-08 |
| 2017-03-31 | $224.00K 10-Q · filed 2017-05-09 |
| 2016-12-31 | $157.00K 10-K · filed 2018-02-27 |
| 2016-09-30 | $177.00K 10-Q · filed 2016-11-07 |
| 2016-06-30 | $197.00K 10-Q · filed 2016-08-04 |
| 2016-03-31 | $217.00K 10-Q · filed 2016-05-05 |
| 2015-12-31 | $232.00K 10-K · filed 2017-02-28 |
| 2015-09-30 | $239.00K 10-Q · filed 2015-11-05 |
| 2015-06-30 | $340.00K 10-Q · filed 2015-08-06 |
| 2015-03-31 | $218.00K 10-Q · filed 2015-05-07 |
| 2014-12-31 | $135.00K 10-K · filed 2016-02-29 |
| 2014-09-30 | $21.00K 10-Q · filed 2014-11-10 |
| 2014-06-30 | $18.00K 10-Q · filed 2014-08-05 |
| 2014-03-31 | $13.00K 10-Q · filed 2014-05-06 |
| 2013-12-31 | $8.00K 10-K · filed 2015-02-26 |
| 2013-09-30 | $2.00K 10-Q · filed 2013-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |